MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,290 Cr | ₹2,040 Cr | ₹1,549 Cr | ₹1,392 Cr | ₹1,134 Cr |
Sales | ₹2,286 Cr | ₹2,037 Cr | ₹1,538 Cr | ₹1,384 Cr | ₹1,129 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹3.21 Cr | ₹2.52 Cr | ₹11 Cr | ₹7.81 Cr | ₹4.87 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr | ₹1,134 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-74 Cr | ₹-6.39 Cr | ₹13 Cr | ₹-136 Cr | ₹53 Cr |
Raw Material Consumed | ₹1,112 Cr | ₹928 Cr | ₹704 Cr | ₹731 Cr | ₹515 Cr |
Opening Raw Materials | ₹203 Cr | ₹151 Cr | ₹118 Cr | ₹92 Cr | ₹90 Cr |
Purchases Raw Materials | ₹727 Cr | ₹665 Cr | ₹574 Cr | ₹446 Cr | ₹396 Cr |
Closing Raw Materials | ₹262 Cr | ₹203 Cr | ₹151 Cr | ₹118 Cr | ₹92 Cr |
Other Direct Purchases / Brought in cost | ₹444 Cr | ₹315 Cr | ₹163 Cr | ₹312 Cr | ₹121 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹37 Cr | ₹24 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr |
Electricity & Power | ₹37 Cr | ₹24 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | ₹0.47 Cr | ₹0.38 Cr |
Employee Cost | ₹294 Cr | ₹239 Cr | ₹220 Cr | ₹197 Cr | ₹168 Cr |
Salaries, Wages & Bonus | ₹275 Cr | ₹223 Cr | ₹204 Cr | ₹180 Cr | ₹162 Cr |
Contributions to EPF & Pension Funds | ₹17 Cr | ₹13 Cr | ₹16 Cr | ₹16 Cr | ₹4.68 Cr |
Workmen and Staff Welfare Expenses | ₹1.35 Cr | ₹0.77 Cr | ₹0.68 Cr | ₹2.09 Cr | ₹0.96 Cr |
Other Employees Cost | ₹0.10 Cr | ₹1.78 Cr | ₹0.40 Cr | - | ₹0.47 Cr |
Other Manufacturing Expenses | ₹137 Cr | ₹96 Cr | ₹13 Cr | ₹50 Cr | ₹64 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹31 Cr | ₹19 Cr | ₹13 Cr | ₹10 Cr | ₹8.30 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹105 Cr | ₹78 Cr | - | ₹39 Cr | ₹56 Cr |
General and Administration Expenses | ₹60 Cr | ₹53 Cr | ₹38 Cr | ₹51 Cr | ₹46 Cr |
Rent , Rates & Taxes | ₹16 Cr | ₹15 Cr | ₹7.18 Cr | ₹15 Cr | ₹12 Cr |
Insurance | - | - | - | ₹12 Cr | ₹8.35 Cr |
Printing and stationery | ₹1.74 Cr | ₹1.34 Cr | ₹0.91 Cr | ₹1.15 Cr | ₹1.08 Cr |
Professional and legal fees | ₹15 Cr | ₹14 Cr | ₹21 Cr | ₹17 Cr | ₹7.87 Cr |
Traveling and conveyance | ₹11 Cr | ₹9.05 Cr | ₹6.12 Cr | ₹2.93 Cr | ₹7.18 Cr |
Other Administration | ₹16 Cr | ₹13 Cr | ₹2.41 Cr | ₹2.72 Cr | ₹8.79 Cr |
Selling and Distribution Expenses | ₹127 Cr | ₹133 Cr | ₹119 Cr | ₹111 Cr | ₹81 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹92 Cr | ₹103 Cr | ₹119 Cr | ₹79 Cr | ₹51 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹36 Cr | ₹31 Cr | - | ₹32 Cr | ₹30 Cr |
Miscellaneous Expenses | ₹26 Cr | ₹45 Cr | ₹107 Cr | ₹16 Cr | ₹0.34 Cr |
Bad debts /advances written off | ₹5.16 Cr | ₹14 Cr | ₹2.63 Cr | ₹14 Cr | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | ₹0.26 Cr | - | ₹0.01 Cr | - |
Losson foreign exchange fluctuations | - | - | - | ₹0.97 Cr | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹21 Cr | ₹31 Cr | ₹104 Cr | ₹0.84 Cr | ₹0.34 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,719 Cr | ₹1,513 Cr | ₹1,232 Cr | ₹1,037 Cr | ₹942 Cr |
Operating Profit (Excl OI) | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr | ₹192 Cr |
Other Income | ₹50 Cr | ₹59 Cr | ₹42 Cr | ₹6.69 Cr | ₹0.33 Cr |
Interest Received | ₹34 Cr | ₹12 Cr | ₹5.97 Cr | ₹1.16 Cr | ₹0.10 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.09 Cr | - | - | ₹0.04 Cr | ₹0.03 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹8.24 Cr | ₹40 Cr | ₹21 Cr | - | - |
Others | ₹8.30 Cr | ₹7.50 Cr | ₹15 Cr | ₹5.50 Cr | ₹0.20 Cr |
Operating Profit | ₹509 Cr | ₹399 Cr | ₹301 Cr | ₹346 Cr | ₹193 Cr |
Interest | ₹11 Cr | ₹9.13 Cr | ₹8.45 Cr | ₹7.99 Cr | ₹8.75 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | ₹3.03 Cr | ₹2.71 Cr | ₹4.17 Cr | ₹2.93 Cr |
Other Interest | ₹11 Cr | ₹6.10 Cr | ₹5.74 Cr | ₹3.82 Cr | ₹5.81 Cr |
PBDT | ₹498 Cr | ₹390 Cr | ₹292 Cr | ₹338 Cr | ₹184 Cr |
Depreciation | ₹74 Cr | ₹52 Cr | ₹45 Cr | ₹36 Cr | ₹27 Cr |
Profit Before Taxation & Exceptional Items | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr | ₹157 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr | ₹157 Cr |
Provision for Tax | ₹109 Cr | ₹72 Cr | ₹61 Cr | ₹64 Cr | ₹36 Cr |
Current Income Tax | ₹113 Cr | ₹72 Cr | ₹57 Cr | ₹67 Cr | ₹32 Cr |
Deferred Tax | ₹-5.11 Cr | ₹1.10 Cr | ₹3.59 Cr | ₹-3.07 Cr | ₹4.47 Cr |
Other taxes | ₹0.43 Cr | ₹-0.33 Cr | ₹0.01 Cr | - | ₹-0.45 Cr |
Profit After Tax | ₹315 Cr | ₹265 Cr | ₹187 Cr | ₹239 Cr | ₹121 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-1.20 Cr | ₹0.99 Cr | ₹-2.25 Cr | ₹-2.60 Cr | ₹-3.73 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr | ₹117 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹778 Cr | ₹509 Cr | ₹335 Cr | ₹85 Cr | ₹2.98 Cr |
Appropriations | ₹1,091 Cr | ₹776 Cr | ₹519 Cr | ₹321 Cr | ₹120 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹22 Cr | ₹-6.99 Cr | ₹10 Cr | ₹-14 Cr | ₹30 Cr |
Equity Dividend % | ₹60.00 | ₹50.00 | ₹25.00 | ₹25.00 | ₹10.00 |
Earnings Per Share | ₹6.92 | ₹5.88 | ₹4.51 | ₹5.76 | ₹2.86 |
Adjusted EPS | ₹6.92 | ₹5.88 | ₹4.51 | ₹5.76 | ₹2.86 |
Compare Income Statement of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹13,505.4 Cr | 1.5% | -14.7% | 89.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹450,595.0 Cr | 0.9% | 4.4% | 50% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,089.0 Cr | 4.6% | -1.1% | 55.6% | Stock Analytics | |
CIPLA | ₹124,175.0 Cr | 2.1% | 0.2% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,625.0 Cr | -1.1% | 12.1% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,672.5 Cr | 1.8% | 0.9% | 41.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.5% |
-14.7% |
89.4% |
SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses